Form 4: Eli Lilly Director Defers Pay into Stock

Eli Lilly & Co. Director Gabrielle Sulzberger acquired 6.129 shares of common stock by deferring cash compensation, increasing her beneficial ownership to 2,728.14 shares.

Summary

• Gabrielle Sulzberger, a Director at Eli Lilly & Co. (LLY), acquired 6.129 shares of common stock.
• The transaction occurred on October 20, 2025, at a price of $808.96 per share.
• The shares were acquired as stock units under the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• These stock units will be settled in shares of common stock following Ms. Sulzberger's separation from service.
• Following this transaction, Ms. Sulzberger's beneficial ownership of Eli Lilly & Co. common stock increased to 2,728.14 shares.

Sentiment

Score: 7

Explanation: Director's decision to defer cash compensation into company stock demonstrates confidence in the company's future performance and aligns her interests with shareholders.

Positives

• The acquisition of shares through compensation deferral demonstrates a director's confidence in the company's long-term prospects.
• Deferring cash compensation into stock aligns the director's financial interests more closely with those of the company's shareholders.

Risks

• The value of the acquired shares is subject to market fluctuations, posing a risk to the director's deferred compensation.
• General market risks and company-specific performance risks could impact the future value of the stock units.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service, indicating a long-term holding strategy for this compensation.

Management Comments

• At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This is a routine insider transaction related to director compensation, common across publicly traded companies, and does not directly reflect broader industry trends or competitive positioning.

Related Party Transactions

• The acquisition of shares by a director in lieu of cash compensation under the Lilly Directors' Deferral Plan constitutes a related-party transaction between the company and its director.

Stakeholder Impact

• Shareholders may view this as a positive signal, as it indicates a director's commitment and alignment with shareholder interests through increased equity ownership.
• The company benefits from retaining cash in the short term by deferring compensation into stock.

Next Steps

• The acquired stock units will be settled in shares of common stock following Gabrielle Sulzberger's separation from service.

Key Dates

Keywords

Eli Lilly, LLY, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Deferred Compensation, Beneficial Ownership